The present invention relates to a stabilized pharmaceutical composition comprising Prasugrel base in micronized form, a surfactant and / or a stabilizer which is bioequivalent to the EFIENT® (prasugrel hydrochloride marketed formulation). The present invention further relates to process for the preparation of stabilized pharmaceutical compositions.
